3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 1/2
1
Status
Unknown
4
Completed
3
Recruiting
2
Terminated
1
Not yet recruiting
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
41
Carcinoma, Non-Small-Cell Lung
28
Colorectal Neoplasms
16
Neoplasms
13
Nasopharyngeal Carcinoma
11
Lung Neoplasms
10
Leukemia, Myeloid, Acute
10
Carcinoma, Hepatocellular
10
Stomach Neoplasms
9
Prostatic Neoplasms
9
Ovarian Neoplasms
8
Multiple Myeloma
8
Squamous Cell Carcinoma of Head and Neck
7
Small Cell Lung Carcinoma
7
Rectal Neoplasms
7
Esophageal Neoplasms
7
Triple Negative Breast Neoplasms
6
Pancreatic Neoplasms
6
Non-Muscle Invasive Bladder Neoplasms
6
Uterine Cervical Neoplasms
5
Recurrence
5
Neoplasm Metastasis
5
Glioblastoma
5
Colonic Neoplasms
5
Brain Neoplasms
5
Adenocarcinoma
5
Urinary Bladder Neoplasms
4
Polycystic Ovary Syndrome
4
Lymphoma, Follicular
4
Fallopian Tube Neoplasms
4
Interventions
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Not yet recruiting
×
Fibrosis
×
Clear all
NCT07529262
2026-04-14
AspiRe HCC
Curtin University
Phase 3
Not yet recruiting
890 enrolled